It is tempting to speculate that this model could also provide a mechanistic understanding of how polymorphisms within the human Hnf4a locus may increase T2D risk, as the genetic sequence, in addition to the epigenotype, could modulate the strength of the promoter-enhancer interaction. This evidence concerns the gene HNF4A and type 2 diabetes mellitus.